Latest Content

Functional precision medicine may help guide faster, more personalized treatment decisions in pediatric brain tumors by testing therapies directly on a patient’s tumor cells.

Nurse practitioner Bridget Hopkins discusses her metastatic breast cancer diagnosis, the role of clinical empathy and finding hope in stage 4 care.

In the last month, I had a revelation about my illness.

FDA approved Lifyorli plus Abraxane, improving survival in platinum-resistant ovarian, fallopian tube and peritoneal cancers.

Five-year ICESECRET data show high recurrence-free rates with cryoablation for small kidney tumors, supporting a minimally invasive treatment option.

Amanda shares how a sudden leukemia diagnosis led to a life-saving transplant and the ongoing challenges of chronic graft-versus-host disease.

Three lifelong friends, all breast cancer survivors, discuss the strength they found in supporting each other.

ctDNA testing could help doctors track response, reduce unnecessary chemo, and identify relapse early for patients with aggressive B cell lymphomas.

For patients navigating a cancer diagnosis, there is a hidden complication that requires vigilance: the risk of a pulmonary embolism.

New findings from the phase 3 SENTRY trial offer encouraging news for patients with myelofibrosis.

Topical HT-001 reduced rash and irritation from EGFR therapies with low levels in the bloodstream and no serious side effects in patients with cancer.

A son shares his decision to become a living liver donor, offering his father a second chance after a cancer diagnosis.

Dr. Amengual outlines how patients with relapsed lymphoma can approach clinical trials, including phases, eligibility and key questions to ask providers.